Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).
Milton S. Hershey Medical Center
Milton S. Hershey Medical Center
City of Hope Medical Center
OHSU Knight Cancer Institute
Mainline Biosciences, Inc.
Stony Brook University
Universitaire Ziekenhuizen KU Leuven
H. Lee Moffitt Cancer Center and Research Institute
Wake Forest University Health Sciences
Tulane University
Instituto Nacional de Cancer, Brazil
New Hope Medical Center
Duke University